201 related articles for article (PubMed ID: 36712866)
1. Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma.
Yue Y; Tao J; An D; Shi L
Front Genet; 2022; 13():1089405. PubMed ID: 36712866
[No Abstract] [Full Text] [Related]
2. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.
Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514
[TBL] [Abstract][Full Text] [Related]
4. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
5. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
Zheng J; Zhang YW; Pan ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
[TBL] [Abstract][Full Text] [Related]
6. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
7. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
Kang Y; Zhu X; Wang X; Liao S; Jin M; Zhang L; Wu X; Zhao T; Zhang J; Lv J; Zhu D
Front Oncol; 2021; 11():641184. PubMed ID: 33816287
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity.
Dai Q; Zhu J; Yang J; Zhang CY; Yang WJ; Pan BS; Yang XR; Guo W; Wang BL
Curr Stem Cell Res Ther; 2024 Mar; ():. PubMed ID: 38561604
[TBL] [Abstract][Full Text] [Related]
10. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.
Lai J; Lin X; Zheng H; Xie B; Fu D
BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Guo F; Hong J
Front Genet; 2020; 11():441. PubMed ID: 32431729
[TBL] [Abstract][Full Text] [Related]
12. mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes.
Wang C; Qin S; Pan W; Shi X; Gao H; Jin P; Xia X; Ma F
Comput Struct Biotechnol J; 2022; 20():2928-2941. PubMed ID: 35765647
[TBL] [Abstract][Full Text] [Related]
13. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma.
Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X
PeerJ; 2023; 11():e16477. PubMed ID: 38025763
[TBL] [Abstract][Full Text] [Related]
14. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
Front Oncol; 2021; 11():626961. PubMed ID: 33747944
[TBL] [Abstract][Full Text] [Related]
15. Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.
Shi X; Liu Y; Cheng S; Hu H; Zhang J; Wei M; Zhao L; Xin S
Front Oncol; 2021; 11():651622. PubMed ID: 34367952
[TBL] [Abstract][Full Text] [Related]
16. Identification of stemness index-related long noncoding RNA SNHG12 in human bladder cancer based on WGCNA.
Zhang B; He Y; Ma G; Zhang L; Qi P; Han D; Yue Z; Shang P
Mol Cell Probes; 2022 Dec; 66():101867. PubMed ID: 36183925
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance.
Li Z; Chen J; Zhu D; Wang X; Chen J; Zhang Y; Lian Q; Gu B
BMC Genom Data; 2022 Jul; 23(1):51. PubMed ID: 35794546
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Stemness-based Subtypes and Construction of a Prognostic Risk Model for Patients with Lung Squamous Cell Carcinoma.
Shen F; Li F; Ma Y; Song X; Guo W
Curr Stem Cell Res Ther; 2024; 19(3):400-416. PubMed ID: 37455452
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
Feng J; Li Y; Wen N
Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626
[TBL] [Abstract][Full Text] [Related]
20. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
Chen M; Wang X; Wang W; Gui X; Li Z
Front Immunol; 2022; 13():829057. PubMed ID: 35833114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]